01—Abstract
Summary
Summary of the 8-K filed June 17, 2026. Cited figures are marked; the original filing is the authoritative source.
Regeneron Pharmaceuticals, Inc. (REGN) filed an 8-K on June 17, 2026, detailing the results of its 2026 Annual Meeting of Shareholders held on June 12, 2026.
The report confirms the election of Class II directors and the ratification of PricewaterhouseCoopers LLP as the independent auditor for fiscal year 2026. Additionally, shareholders provided advisory approval for executive compensation. Key outcomes include the successful election of all nominated directors, indicating strong shareholder confidence in the current board's leadership.
The ratification of the auditor received substantial support, reinforcing the company's commitment to financial transparency and robust auditing practices. The advisory vote on executive compensation also passed with a significant majority, suggesting shareholder alignment with the company's compensation philosophy for its named executive officers.
02—Key points
Key Highlights
- All nominated Class II directors were elected to serve until the 2027 Annual Meeting of Shareholders.
- PricewaterhouseCoopers LLP was ratified as Regeneron's independent registered public accounting firm for the fiscal year ending December 31, 2026, with strong shareholder approval.
- Shareholders approved, on an advisory basis, the compensation of the Company's named executive officers.
- The election of directors saw significant 'For' votes, with Dr. Huda Y. Zoghbi and Dr. David P. Schenkein receiving over 100 million and 99 million 'For' votes, respectively.
- The ratification of the independent auditor received overwhelming support, with approximately 93% of the cast votes in favor.
- The advisory vote on executive compensation also garnered substantial shareholder support, with over 90% of the cast votes in favor.
03—Questions
Frequently Asked Questions
What were the key outcomes of Regeneron's 2026 Annual Meeting of Shareholders?
The key outcomes include the election of all nominated directors, the ratification of PricewaterhouseCoopers LLP as the independent auditor for fiscal year 2026, and the advisory approval of executive compensation.
Were there any contested director elections?
No, all nominated directors were elected with a significant majority of 'For' votes, indicating shareholder confidence in the nominated individuals.
What is the significance of ratifying the independent auditor?
Ratifying the independent auditor, PricewaterhouseCoopers LLP, is a routine but important vote that signifies shareholder confidence in the company's financial reporting integrity and the auditor's independence.
What does an advisory vote on executive compensation mean?
An advisory vote on executive compensation, often referred to as a 'say-on-pay' vote, allows shareholders to express their opinion on the company's executive compensation policies and practices. While non-binding, a strong majority in favor, as seen here, generally indicates shareholder satisfaction.
04—Continue